HDAC inhibitors decrease mogamulizumab efficacy with downregulation of CCR4 in T-cell lymphoma

被引：0
|
作者：
Kitadate, Akihiro [1 ]
Ikeda, Sho [1 ]
Abe, Fumito [1 ]
Teshima, Kazuaki [1 ]
Takahashi, Naoto [1 ]
Matsue, Kosei [2 ]
Tagawa, Hiroyuki [1 ]
机构：
[1] Akita Univ, Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 010, Japan
[2] Div Hematol, Akita 010, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Malignant lymphoma; HDAC inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-2025
引用
收藏
页码：506 / 506
页数：1
相关论文
共 50 条
  • [1] Histone Deacetylase Inhibitors Downregulate CCR4 Expression and Decrease Mogamulizumab Efficacy in CCR4-Positive Mature T-Cell Lymphomas
    Kitadate, Akihiro
    Ikeda, Sho
    Abe, Fumito
    Takahashi, Naoto
    Shimizu, Norio
    Matsue, Kosei
    Tagawa, Hiroyuki
    BLOOD, 2017, 130
  • [2] Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas
    Kitadate, Akihiro
    Ikeda, Sho
    Abe, Fumito
    Takahashi, Naoto
    Shimizu, Norio
    Matsue, Kosei
    Tagawa, Hiroyuki
    HAEMATOLOGICA, 2018, 103 (01) : 126 - 135
  • [3] Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma
    Beygi, Sara
    Duran, George E.
    Fernandez-Pol, Sebastian
    Rook, Alain H.
    Kim, Youn H.
    Khodadoust, Michael S.
    BLOOD, 2022, 139 (26) : 3732 - 3736
  • [4] Immunohistochemistry for CCR4C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphoma
    Fujii, Keiichiro
    Sakamoto, Yuma
    Masaki, Ayako
    Murase, Takayuki
    Tashiro, Yukie
    Yonekura, Kentaro
    Utsunomiya, Atae
    Ito, Asahi
    Kusumoto, Shigeru
    Iida, Shinsuke
    Ueda, Ryuzo
    Ishida, Takashi
    Inagaki, Hiroshi
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2021, 7 (01): : 52 - 60
  • [5] Resistance to Mogamulizumab Is Associated with Loss of CCR4 in Cutaneous T Cell Lymphoma
    Beygi, Sara
    Fernandez-Pol, Sebastian
    Duran, George
    Kim, Youn H.
    Khodadoust, Michael S.
    BLOOD, 2021, 138
  • [6] CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment
    Sakamoto, Yuma
    Ishida, Takashi
    Masaki, Ayako
    Murase, Takayuki
    Yonekura, Kentaro
    Tashiro, Yukie
    Tokunaga, Masahito
    Utsunomiya, Atae
    Ito, Asahi
    Kusumoto, Shigeru
    Iida, Shinsuke
    Ueda, Ryuzo
    Inagaki, Hiroshi
    BLOOD, 2018, 132 (07) : 758 - 761
  • [7] Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma
    Ohno, Nobuhiro
    Kobayashi, Seiichiro
    Ishigaki, Tomohiro
    Yuji, Koichiro
    Kobayashi, Masayuki
    Sato, Koota
    Watanabe, Nobukazu
    Tojo, Arinobu
    Uchimaru, Kaoru
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (05) : 683 - 685
  • [8] Effects of CCR4 antagonists in cutaneous T-cell lymphoma cells
    Enriquez, J. S.
    Bijani, P.
    Duvic, M.
    Ni, X.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S80 - S80
  • [9] Identification of CCR4 Mutations in Adult T-cell Leukemia/Lymphoma by Immunohistochemistry
    Wang, Hao-Wei
    Palisoc, Maryknoll
    Navarro, Winnifred
    Xi, Liqiang
    Jaffe, Elaine
    Raffeld, Mark
    Pittaluga, Stefania
    LABORATORY INVESTIGATION, 2018, 98 : 563 - 563
  • [10] Tucidinostat restores CCR4 expression in adult T-cell leukemia/lymphoma
    Kawata, Takahito
    Shimizu, Takuya
    Shindo, Takero
    Fujiwara, Kensuke
    Morimoto, Suguru
    Watanabe, Mitsumasa
    HAEMATOLOGICA, 2024, 109 (03) : 1007 - 1009
12345